TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 393 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $14,000 | +55.6% | 1,027 | +62.5% | 0.00% | – |
| Q1 2022 | $9,000 | -18.2% | 632 | -19.4% | 0.00% | – |
| Q4 2021 | $11,000 | +33.5% | 784 | +55.9% | 0.00% | – |
| Q3 2021 | $8,239 | -2.7% | 503 | 0.0% | 0.00% | – |
| Q2 2021 | $8,465 | -53.5% | 503 | -49.5% | 0.00% | -100.0% |
| Q1 2021 | $18,187 | -15.7% | 996 | -15.9% | 0.00% | 0.0% |
| Q4 2020 | $21,567 | +2.0% | 1,185 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $21,140 | -0.5% | 1,185 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $21,247 | +40.5% | 1,185 | +19.0% | 0.00% | 0.0% |
| Q1 2020 | $15,119 | -56.9% | 996 | -44.0% | 0.00% | -33.3% |
| Q4 2019 | $35,060 | +44.8% | 1,777 | +26.2% | 0.00% | +50.0% |
| Q3 2019 | $24,218 | -2.8% | 1,408 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $24,922 | +22.8% | 1,408 | +41.4% | 0.00% | 0.0% |
| Q1 2019 | $20,289 | – | 996 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Y.D. More Investments Ltd | 1,498,811 | $24,700,380 | 5.57% |
| TFG Asset Management GP Ltd | 1,903,662 | $31,372,350 | 4.20% |
| Clean Yield Group | 542,342 | $8,937,796 | 3.81% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,467,952 | $24,192 | 3.67% |
| Mondrian Investment Partners LTD | 4,081,715 | $67,266,663 | 1.48% |
| Sippican Capital Advisors | 82,235 | $1,355,233 | 1.30% |
| Psagot Value Holdings Ltd. / (Israel) | 174,300 | $2,830 | 1.18% |
| Clal Insurance Enterprises Holdings Ltd | 4,365,500 | $71,943 | 1.08% |
| Legacy Wealth Asset Management, LLC | 123,303 | $2,032,033 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 1,817,972 | $29,960,175 | 0.64% |